Similarly, Hur et al. found that 46.9% of patients with low-expressed p53 in their tumor tissue achieved pCR, whereas only 24.5% of patients with overexpressed p53 were able to achieve pCR [76]. The gene discussed is TP53; the disease is neoplasm.